Sue E Gardner1, Ambar Haleem2, Ying-Ling Jao3, Stephen L Hillis4, John E Femino5, Phinit Phisitkul5, Kristopher P Heilmann2, Shannon M Lehman3, Carrie L Franciscus6. 1. College of Nursing, The University of Iowa, Iowa City, IA sue-gardner@uiowa.edu. 2. Department of Internal Medicine, The University of Iowa, Iowa City, IA. 3. College of Nursing, The University of Iowa, Iowa City, IA. 4. Department of Radiology, The University of Iowa, Iowa City, IA Department of Biostatistics, The University of Iowa, Iowa City, IA Comprehensive Access and Delivery Research and Evaluation Center, Iowa City VA Health Care System, Iowa City, IA. 5. Department of Orthopedic Surgery, The University of Iowa, Iowa City, IA. 6. Comprehensive Access and Delivery Research and Evaluation Center, Iowa City VA Health Care System, Iowa City, IA.
Abstract
OBJECTIVE: We examined associations between ulcer bioburden and ulcer outcomes in neuropathic diabetic foot ulcers (DFUs) that lacked clinical signs of infection. RESEARCH DESIGN AND METHODS: Three dimensions of bioburden (i.e., microbial load, microbial diversity, and the presence of likely pathogens) were measured at baseline using swab cultures obtained by Levine's technique. Subjects were assessed every 2 weeks for 26 weeks to determine the rate of healing and development of infection-related complications. Foot ulcers were off-loaded using total-contact casts and routinely debrided. To establish associations between bioburden and rate of healing, Cox proportional hazards and least squares regression were used after adjusting for ulcer depth, surface area, and duration. RESULTS: A total of 77 subjects completed the study. Sixty-five (84.4%) had ulcers that healed during follow-up; weeks-to-closure ranged from 2 to 26 (median 4.0). Mean (± SD) percent reduction in surface area/week was 25.0% (± 23.33). Five (6.5%) of the DFUs developed an infection-related complication. None of the bioburden dimensions (i.e., microbial load, microbial diversity, or presence of likely pathogens) was significantly associated with weeks-to-closure or percent reduction in surface area per week. Weeks-to-closure was best predicted by ulcer duration, depth, and surface area (c-statistic = 0.75). CONCLUSIONS: Culturing DFUs that showed no clinical signs of infection had no predictive value for outcomes of DFUs managed with total-contact casts and routine debridement. These findings support recommendations of the Infectious Disease Society of America that culturing and antibiotics should be avoided in treating DFUs that show no clinical signs of infection.
OBJECTIVE: We examined associations between ulcer bioburden and ulcer outcomes in neuropathic diabetic foot ulcers (DFUs) that lacked clinical signs of infection. RESEARCH DESIGN AND METHODS: Three dimensions of bioburden (i.e., microbial load, microbial diversity, and the presence of likely pathogens) were measured at baseline using swab cultures obtained by Levine's technique. Subjects were assessed every 2 weeks for 26 weeks to determine the rate of healing and development of infection-related complications. Foot ulcers were off-loaded using total-contact casts and routinely debrided. To establish associations between bioburden and rate of healing, Cox proportional hazards and least squares regression were used after adjusting for ulcer depth, surface area, and duration. RESULTS: A total of 77 subjects completed the study. Sixty-five (84.4%) had ulcers that healed during follow-up; weeks-to-closure ranged from 2 to 26 (median 4.0). Mean (± SD) percent reduction in surface area/week was 25.0% (± 23.33). Five (6.5%) of the DFUs developed an infection-related complication. None of the bioburden dimensions (i.e., microbial load, microbial diversity, or presence of likely pathogens) was significantly associated with weeks-to-closure or percent reduction in surface area per week. Weeks-to-closure was best predicted by ulcer duration, depth, and surface area (c-statistic = 0.75). CONCLUSIONS: Culturing DFUs that showed no clinical signs of infection had no predictive value for outcomes of DFUs managed with total-contact casts and routine debridement. These findings support recommendations of the Infectious Disease Society of America that culturing and antibiotics should be avoided in treating DFUs that show no clinical signs of infection.
Authors: David L Steed; Christopher Attinger; Theodore Colaizzi; Mary Crossland; Michael Franz; Lawrence Harkless; Andrew Johnson; Hans Moosa; Martin Robson; Thomas Serena; Peter Sheehan; Aristidis Veves; Laurel Wiersma-Bryant Journal: Wound Repair Regen Date: 2006 Nov-Dec Impact factor: 3.617
Authors: Rodrigo E Mendes; Katia A Kiyota; Jussimara Monteiro; Mariana Castanheira; Soraya S Andrade; Ana C Gales; Antonio C C Pignatari; Sergio Tufik Journal: J Clin Microbiol Date: 2006-11-08 Impact factor: 5.948
Authors: G E Reiber; L Vileikyte; E J Boyko; M del Aguila; D G Smith; L A Lavery; A J Boulton Journal: Diabetes Care Date: 1999-01 Impact factor: 19.112
Authors: Lindsay R Kalan; Jacquelyn S Meisel; Michael A Loesche; Joseph Horwinski; Ioana Soaita; Xiaoxuan Chen; Aayushi Uberoi; Sue E Gardner; Elizabeth A Grice Journal: Cell Host Microbe Date: 2019-04-18 Impact factor: 21.023
Authors: Xavier Marchand-Senécal; Ian A Brasg; Robert Kozak; Marion Elligsen; Christie Vermeiren; Antoine J Corbeil; Kevin R Barker; Kevin Katz; Jeff E Powis; Wayne L Gold; Jerome A Leis Journal: Open Forum Infect Dis Date: 2020-12-13 Impact factor: 3.835
Authors: Kyung R Min; Adriana Galvis; Katherine L Baquerizo Nole; Rohita Sinha; Jennifer Clarke; Robert S Kirsner; Dragana Ajdic Journal: PLoS One Date: 2020-01-24 Impact factor: 3.240